ADDvise acquires Labplan Ltd.

22-12-2023   Regulatory press release

ADDvise Group has entered into a share purchase agreement with the owners of Labplan Ltd. (“Labplan”) regarding the acquisition of all shares of Labplan. Closing takes place today.

Labplan, based in Kildare, Ireland, is a distributor of specialized advanced instruments, consumables and service to the life science and biopharmaceutical industry. The company serves large multi-national pharma companies as well as government-backed research institutions in Ireland and Northern Ireland.

Labplan’s revenue for the last twelve months per October 31, 2023, amounted to EUR 16.9 million, with an adjusted EBITDA of EUR 3.9 million, corresponding to an adjusted EBITDA margin of 23.0 percent.

The acquisition will be consummated at an initial cash consideration of EUR 13.3 million, and performance-based payments expected to amount to EUR 7.2 million in aggregate over a two-year period.

The acquisition is financed through own funds. ADDvise assesses that the acquisition will have a positive impact on ADDvise’s earnings per share during the financial year 2024.

Adviser

Mangold Fondkommission AB acted as financial adviser to ADDvise in connection with the acquisition.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Hanna Myhrman, General Counsel
+46 709 82 92 23
hanna.myhrman@addvisegroup.se

Important information

This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 22, 2023 at 17:40 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

Invitation to presentation of interim report October 1 – December 31, 2024

Non-regulatory

ADDvise Group publishes its interim report October 1 – December 31, 2024 on Thursday, February 20, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report. Webcast If you…

Invitation to presentation of interim report July 1 – September 30, 2024

Non-regulatory

Media, investors and analysts are invited to attend a presentation of the interim report for the period July 1 – September 30, 2024. The presentation will take place on October 24, 2024, at 14:00 (CEST) / 08:00 AM (EST). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report in a webcast and…

Invitation to presentation of interim report January 1 – March 31, 2024

Non-regulatory

ADDvise Group’s interim report for the period January 1 – March 31, 2024 will be published on April 18, 2024 at 07:45 (CEST). Investors, analysts, and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…